TrialJournal of clinical psychopharmacology2018

Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence.

Randi Melissa Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.